Future4Care Launches Second Edition of Its Go-To-Market Program for Digital Health Startups
Generali continues to support digital health innovation – discover how this new program opens doors to future collaborations with startups shaping the healthcare of tomorrow.
Future4Care, the European innovation hub co-founded by Generali, is once again opening its doors to visionary digital health startups through the second edition of its Go-To-Market Program. This equity-free, one-year initiative is designed to accelerate startups’ entry into the French and German healthcare markets. It brings together startups from around the world working in PharmaTech, Prevention, HospitalTech, and Healthy Aging, offering them:
- Expert mentorship from industry leaders
- Strategic market access insights
- Educational activities tailored to healthcare innovation
- Hybrid engagement model for global flexibility
The program officially kicks off on November 3, 2025, and targets startups from Seed to Series B stages, especially those innovating in PharmaTech, Prevention, HospitalTech, and Healthy Aging.
With over 100 partners and startups already part of its thriving ecosystem, Future4Care is committed to fostering cross-sector collaboration and driving sustainable innovation in Europe’s fragmented healthcare systems.
As a founding member, Generali continues to support Future4Care’s mission to reshape the future of healthcare through digital transformation. This initiative reflects our broader commitment to innovation – not only as a key driver of excellence within our Lifetime Partner 27: Driving Excellence strategic plan, but also as a behaviour that guides how we work every day across the organization.
The launch of this new Go-To-Market Program represents a valuable opportunity for Generali’s teams to explore potential collaborations with emerging startups in the healthtech space. By engaging with these innovators, we can gain fresh perspectives, co-develop solutions, and strengthen our role in shaping the future of health and well-being in Europe.
For further information, you can write to filippomaria.stefania@generali.com